Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
Cells
|
October 14, 2022
Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection
Emil Johansson, Priscilla F Kerkman, Lydia Scharf, et al.
Journal of Virology
|
May 28, 2003
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene
Annika C Karlsson, Steven G Deeks, Jason D Barbour, et al.
The American Journal of Clinical Nutrition
|
February 8, 2007
Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients
Joseph Rafter, Michael Bennett, Giovanna Caderni, et al.
Science Immunology
|
September 14, 2021
Identification of resident memory CD8<sup>+</sup> T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue
Julia Niessl, Takuya Sekine, Joshua Lange, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 7, 2023
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
K E Smedby, T Wästerlid, E Tham, et al.
Nature Medicine
|
January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
Yu Gao, Curtis Cai, Alba Grifoni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2023
Functional SARS-CoV-2 cross-reactive CD4<sup>+</sup> T cells established in early childhood decline with age
Marion Humbert, Anna Olofsson, David Wullimann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 6, 2013
Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo
H Lennernäs, L Aarons, P Augustijns, et al.
Leukemia
|
October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
G Fraser, P Cramer, F Demirkan, et al.
Science Translational Medicine
|
July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R Müller, Takuya Sekine, Darya Trubach, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
Cells
|
October 14, 2022
Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection
Emil Johansson, Priscilla F Kerkman, Lydia Scharf, et al.
Journal of Virology
|
May 28, 2003
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene
Annika C Karlsson, Steven G Deeks, Jason D Barbour, et al.
The American Journal of Clinical Nutrition
|
February 8, 2007
Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients
Joseph Rafter, Michael Bennett, Giovanna Caderni, et al.
Science Immunology
|
September 14, 2021
Identification of resident memory CD8<sup>+</sup> T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue
Julia Niessl, Takuya Sekine, Joshua Lange, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 7, 2023
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
K E Smedby, T Wästerlid, E Tham, et al.
Nature Medicine
|
January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
Yu Gao, Curtis Cai, Alba Grifoni, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2023
Functional SARS-CoV-2 cross-reactive CD4<sup>+</sup> T cells established in early childhood decline with age
Marion Humbert, Anna Olofsson, David Wullimann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 6, 2013
Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo
H Lennernäs, L Aarons, P Augustijns, et al.
Leukemia
|
October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
G Fraser, P Cramer, F Demirkan, et al.
Science Translational Medicine
|
July 12, 2023
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Thomas R Müller, Takuya Sekine, Darya Trubach, et al.
Page
of 21